The preterm birth diagnostic test kit market is projected to grow from USD 163.8 million in 2025 to USD 340.7 million by 2035, at a CAGR of 7.6%. PAMG-1 Test will dominate with a 62.6% market share, while blood will lead the sample segment with a 42.2% share.